Apricus Wealth, LLC Relmada Therapeutics, Inc. Transaction History
Apricus Wealth, LLC
- $177 Million
- Q3 2025
A detailed history of Apricus Wealth, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Apricus Wealth, LLC holds 47,462 shares of RLMD stock, worth $107,264. This represents 0.05% of its overall portfolio holdings.
Number of Shares
47,462
Previous 47,462
-0.0%
Holding current value
$107,264
Previous $28,000
239.29%
% of portfolio
0.05%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding RLMD
# of Institutions
56Shares Held
5.42MCall Options Held
0Put Options Held
0-
Driehaus Capital Management LLC Chicago, IL740KShares$1.67 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA619KShares$1.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$1.3 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD397KShares$896,1210.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$822,8140.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $64.7M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...